426 - 450 of 34.939
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Novo Nordisk Call 280,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 4,61x
- Analysis
- Pfizer Call 26,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 9,68x
- Analysis
- Adecco Call 25,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 6,75x
- Analysis
- Novo Nordisk Call 410,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,11x
- Analysis
- Skyworks Solutions Call 60,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 4,66x
- Analysis
- Vertex Pharmaceuticalsorporated Call 350,00 16 Jan 2026
- Goldman Sachs
- 16.01.26
- 5,00x
- Analysis
- Newmont Goldcorp Call 110,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 7,69x
- Analysis
- AMD Call 195,00 16 Jan 2026
- Goldman Sachs
- 16.01.26
- 4,99x
- Analysis
- Novo Nordisk Call 390,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 5,98x
- Analysis
- Swiss Life Holding Call 850,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 7,95x
- Analysis
- Adecco Call 30,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 10,94x
- Analysis
- Novo Nordisk Call 350,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 6,23x
- Analysis
- Abbvie Inc Call 210,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 19,08x
- Analysis
- Weibo Corp Call 16,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 5,58x
- Analysis
- Adecco Call 40,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 8,29x
- Analysis
- Novo Nordisk Call 500,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 6,70x
- Analysis
- Novo Nordisk Call 300,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 5,16x
- Analysis
- Vertex Pharmaceuticalsorporated Call 360,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 10,75x
- Analysis
- Walmart Call 115,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 18,65x
- Analysis
- Accenture Call 240,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 10,79x
- Analysis
- BBVA Call 20,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 14,44x
- Analysis
- AMD Call 270,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 3,56x
- Analysis
- Novo Nordisk Call 480,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,78x
- Analysis
- Novo Nordisk Call 490,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 6,99x
- Analysis
- Novo Nordisk Call 330,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 5,85x
- Analysis